Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 84

1.

TIMP3 Modulates GHR Abundance and GH Sensitivity.

Zhang Y, Wang X, Loesch K, May LA, Davis GE, Jiang J, Frank SJ.

Mol Endocrinol. 2016 Jun;30(6):587-99. doi: 10.1210/me.2015-1302. Epub 2016 Apr 13.

PMID:
27075707
2.

GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.

Liu Y, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ.

Mol Endocrinol. 2016 May;30(5):504-17. doi: 10.1210/me.2015-1319. Epub 2016 Mar 22.

PMID:
27003442
3.

Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.

Khodneva Y, Shalev A, Frank SJ, Carson AP, Safford MM.

Diabetes Res Clin Pract. 2016 May;115:115-21. doi: 10.1016/j.diabres.2016.01.021. Epub 2016 Jan 15.

PMID:
26818894
4.

Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human β-Cells.

Chen H, Kleinberger JW, Takane KK, Salim F, Fiaschi-Taesch N, Pappas K, Parsons R, Jiang J, Zhang Y, Liu H, Wang P, Bender AS, Frank SJ, Stewart AF.

Diabetes. 2015 Nov;64(11):3784-97. doi: 10.2337/db15-0083. Epub 2015 Jul 9.

5.

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice.

Cordoba-Chacon J, Majumdar N, List EO, Diaz-Ruiz A, Frank SJ, Manzano A, Bartrons R, Puchowicz M, Kopchick JJ, Kineman RD.

Diabetes. 2015 Sep;64(9):3093-103. doi: 10.2337/db15-0370. Epub 2015 May 26.

6.

Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Gan Y, Buckels A, Liu Y, Zhang Y, Paterson AJ, Jiang J, Zinn KR, Frank SJ.

Mol Endocrinol. 2014 Nov;28(11):1841-54. doi: 10.1210/me.2014-1174. Epub 2014 Sep 11. Erratum in: Mol Endocrinol. 2015 Feb;29(2):332.

7.

Dynamic analysis of GH receptor conformational changes by split luciferase complementation.

Liu Y, Berry PA, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ.

Mol Endocrinol. 2014 Nov;28(11):1807-19. doi: 10.1210/me.2014-1153. Epub 2014 Sep 4.

8.

Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β.

Zhao Y, Xiao X, Frank SJ, Lin HY, Xia Y.

Am J Physiol Endocrinol Metab. 2014 Jul 15;307(2):E186-98. doi: 10.1152/ajpendo.00652.2013. Epub 2014 Jun 3.

9.

Circadian clock control of endocrine factors.

Gamble KL, Berry R, Frank SJ, Young ME.

Nat Rev Endocrinol. 2014 Aug;10(8):466-75. doi: 10.1038/nrendo.2014.78. Epub 2014 May 27. Review.

10.

Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.

Gan Y, Paterson AJ, Zhang Y, Jiang J, Frank SJ.

Endocrinology. 2014 Mar;155(3):1000-9. doi: 10.1210/en.2013-1732. Epub 2013 Jan 1.

11.

IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.

Gan Y, Zhang Y, Buckels A, Paterson AJ, Jiang J, Clemens TL, Zhang ZY, Du K, Chang Y, Frank SJ.

Mol Endocrinol. 2013 Nov;27(11):1969-79. doi: 10.1210/me.2013-1178. Epub 2013 Sep 12.

12.

Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes.

Zhang Y, Liu Y, Li X, Gao W, Zhang W, Guan Q, Jiang J, Frank SJ, Wang X.

Lipids Health Dis. 2013 Apr 30;12:56. doi: 10.1186/1476-511X-12-56.

13.

Hepatic growth hormone resistance after acute injury.

Corrick RM, Li L, Frank SJ, Messina JL.

Endocrinology. 2013 Apr;154(4):1577-88. doi: 10.1210/en.2012-2134. Epub 2013 Feb 15.

14.

The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice.

List EO, Berryman DE, Funk K, Gosney ES, Jara A, Kelder B, Wang X, Kutz L, Troike K, Lozier N, Mikula V, Lubbers ER, Zhang H, Vesel C, Junnila RK, Frank SJ, Masternak MM, Bartke A, Kopchick JJ.

Mol Endocrinol. 2013 Mar;27(3):524-35. doi: 10.1210/me.2012-1330. Epub 2013 Jan 24.

15.

The role of prolactin receptor in GH signaling in breast cancer cells.

Xu J, Sun D, Jiang J, Deng L, Zhang Y, Yu H, Bahl D, Langenheim JF, Chen WY, Fuchs SY, Frank SJ.

Mol Endocrinol. 2013 Feb;27(2):266-79. doi: 10.1210/me.2012-1297. Epub 2012 Nov 28.

16.

Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.

Deng L, Jiang J, Frank SJ.

Endocrinology. 2012 May;153(5):2311-22. doi: 10.1210/en.2011-1452. Epub 2012 Mar 13.

17.

Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.

Ma F, Wei Z, Shi C, Gan Y, Lu J, Frank SJ, Balducci J, Huang Y.

Mol Endocrinol. 2011 Dec;25(12):2119-33. doi: 10.1210/me.2011-1052. Epub 2011 Oct 27.

18.

Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping.

Jiang J, Wan Y, Wang X, Xu J, Harris JM, Lobie PE, Zhang Y, Zinn KR, Waters MJ, Frank SJ.

Endocrinology. 2011 Dec;152(12):4777-88. doi: 10.1210/en.2011-1336. Epub 2011 Oct 11.

19.

A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway.

Zheng Y, Qin H, Frank SJ, Deng L, Litchfield DW, Tefferi A, Pardanani A, Lin FT, Li J, Sha B, Benveniste EN.

Blood. 2011 Jul 7;118(1):156-66. doi: 10.1182/blood-2010-01-266320. Epub 2011 Apr 28.

20.

γ-Secretase-mediated growth hormone receptor proteolysis: mapping of the intramembranous cleavage site.

Wang X, Cowan JW, Gerhart M, Zelickson BR, Jiang J, He K, Wolfe MS, Black RA, Frank SJ.

Biochem Biophys Res Commun. 2011 May 13;408(3):432-6. doi: 10.1016/j.bbrc.2011.04.041. Epub 2011 Apr 13.

PMID:
21514282
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk